Boston Trust Walden Corp Lowers Stock Position in Colgate-Palmolive (NYSE:CL)
Boston Trust Walden Corp trimmed its position in Colgate-Palmolive (NYSE:CL – Free Report) by 2.6% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 235,370 shares of the company’s stock after selling 6,370 shares during the period. Boston Trust Walden Corp’s holdings in Colgate-Palmolive were worth $18,761,000 […]